January 7, 2015
An innovation grant received from Swiss Commission for Technology and Innovation (CTI) to address unmet medical needs in inflammation
Alpine Institute for Drug Discovery (AiDD) and University of Geneva have received a 238’000 CHF grant from the Swiss Commission for Technology and Innovation (CTI) to pursue early stage research on a novel undisclosed target addressing unmet needs in inflammation using a novel and unique multi-dimensional approach. AiDD will collaborate with the laboratory of Professor Leonardo Scapozza of the School of Pharmaceutical Sciences (EPGL) at the University of Geneva to perform assay development, screening, and hit validation.

About the CTI
The Swiss Commission for Technology and Innovation (CTI) is the Swiss Confederation innovation promotion agency supporting R&D projects, entrepreneurship and the development of start-up companies in Switzerland.
For more information about CTI: see CTI